产品

您的位置:首页 > 食品资讯 > 外讯导读 > 欧盟评估冻干牛樟芝菌丝体作为新型食品的安全性

欧盟评估冻干牛樟芝菌丝体作为新型食品的安全性

来源:好招商食品网 外讯导读   |  2024-04-25
   好招商食品网讯  2022年6月29日,据欧盟食品安全局(EFSA )消息,欧盟营养、新型食品和食物过敏原(NDA)研究小组就冻干牛樟芝菌丝体(freeze-dried mycelia of Antrodia camphorata)作为新型食品的安全性发表科学意见。
 
  经过评估,专家小组得出结论,在提议的使用条件下,冻干牛樟芝菌丝体作为新型食品对于14岁及以上的个人来说是安全的。部分原文报道如下:
 
  Following a request from the European Commission, the EFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA) was asked to deliver an opinion on freeze-dried mycelia of Antrodia camphorata as a novel food (NF) pursuant to Regulation (EU) 2015/2283. The NF is produced by solid-state cultivation from tissue cultures derived from the fungus Antrodia camphorata. The applicant intends to market the NF in food supplements at a maximum dose of 990 mg per day. The target population is the general population. The NF mainly consists of carbohydrates, proteins and fats, and it contains numerous constituents, such as β-glucans, antroquinonol and triterpenoids. Taking into account the composition of the NF and the proposed conditions of use, the consumption of the NF is not nutritionally disadvantageous. There are no concerns regarding genotoxicity of the NF. based on a 90-day repeated dose toxicity study and a prenatal developmental toxicity study performed with the NF, the Panel derives a safe level of 16.5 mg/kg body weight per day. The Panel concludes that the NF, freeze-dried mycelia of Antrodia camphorata, is safe at the proposed use level for individuals aged 14 years and above.
 

TAGS:过敏原 食品 安全局 食品安全 欧盟
免责声明:本站部分文章转载自网络,图文仅供行业学习交流使用,不做任何商业用途。文章仅代表原作者个人观点,其原创性及文章内容中图文的真实性、完整性等未经本站核实,仅供读者参考。
上一篇: 欧盟评估转基因地衣芽孢杆菌菌株NZYM-AY生产的α-淀粉酶的安全性
下一篇: 欧盟评估延长使用解脂耶氏酵母生物质作为新型食品的安全性